Application Deadline: December 15, 2021
The research proposed for funding may be in any area of cancer research, including basic research, clinical research, population-based research and translational research across the cancer care continuum (prevention, early detection, diagnosis, treatment , supportive and palliative care, and survivorship). These grants are intended to catalyze subsequent application for funding from other funding sources, not to support longer term research.
Each grant will provide US$55,000 over two years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborator, postdoctoral or clinical research fellows, graduate students (including tuition costs), and/or research assistants, research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses. Indirect costs is limited to no more than 10% of the total grant amount. Up to US$10,000 may be allocated from the grant to support travel applicable to the research project and relevant scientific meetings, including mandatory attendance at the 2023 AACR Annual Meeting and biennial AORTIC conference. The grants are not intended for principal investigators outside of Africa, although collaborative research projects are encouraged. All funds provided must be spent in Africa with the exception of limited support for travel to international scientific meetings and conferences.
At the start of the grant term on July 1, 2022, the Principal investigator (PI) must:
- Be a beginning investigator, defined as a clinician or scientist who received his or her highest degree of study within the past ten years. An earned academic (or research) doctorate [such as a Doctor of Philosophy (PhD)], or medical degree [such as a Doctor of Medicine (MD),Doctor of Osteopathy (DO) or Bachelor of Medicine Bachelor of Surgery (MB ChB, MB BS, BM MCh, etc.)] which is considered the highest degree of study in most African countries. When an investigator has received multiple terminal degrees, the calculation will be based on the date of award of the most recent degree.
- Be a current member with AORTIC. Note: AORTIC membership is also mandatory at LOI stage.
- Reside in and be conducting research in Africa with particular relevance to the African cancer burden on the continent. Proof of residency is required.
- Have legal residency status in Africa.
- Not have received a BIG CAT award in prior years.
Applicants must have legal residency status in Africa. A list of eligible countries can be found in the Competitive Letter of Intent Program Guidelines and Application Instructions. Proof of residency is required.
Competitive Letter of Intent Program Guidelines and Application Instructions are available for download here.
The BIG Cat program requires applicants to complete an online Letter of Intent submission by 5:00 p.m. UTC (1:00 p.m. Eastern Time) on Wednesday, December 15, 2021, using the ProposalCentral website at https://proposalcentral.com/.
For More Information: